Virility Medical Files Patent Infringement Lawsuit Against Morari Medical in the U.S.

Virility Medical Ltd. ("Virility Medical"), a leading innovator in the sexual health industry, filed a patent infringement lawsuit on March 18, 2025, in the United States District Court for the District of Delaware against Morari, Inc. (d/b/a. Morari Medical).

Morari recently announced that it received clearance from the United States Food and Drug Administration ("FDA") to market the MOR product. As explained in the recently filed complaint, Morari's FDA submission asserted that the MOR product is "substantially equivalent" to Virility Medical's own FDA cleared product. Indeed, Morari's CEO, Jeff Bennett, has explained that Morari "leverage[ed]" Virility Medical's "existing research and technology" in order to "expedite [its] product's development and market entry."

The Virility Medical patents asserted in the complaint are U.S. Patent Nos. 10,773,072; 11,471,666; and 12,194,289. Virility Medical also owns additional patents and pending patent applications.